(Q35023966)

5 August 2017

1 reference

title

Can claudication be improved with medication? (English)

1 reference

5 August 2017

1 reference

Michael S Conners

1

1 reference

5 August 2017

Samuel R Money

series ordinal

2

1 reference

5 August 2017

publication date

1 December 2002

1 reference

Seminars in Vascular Surgery

5 August 2017

published in

1 reference

5 August 2017

volume

15

1 reference

5 August 2017

issue

4

1 reference

5 August 2017

page(s)

237-244

1 reference

Medical treatment of peripheral arterial disease and claudication

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2802%2970023-9

7 January 2021

Low-dose aspirin and subsequent peripheral arterial surgery in the Physicians' Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2802%2970023-9

7 January 2021

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2802%2970023-9

7 January 2021

Drug therapy: vasodilator drugs in peripheral vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2802%2970023-9

7 January 2021

Effect of verapamil in intermittent claudication A randomized, double-blind, placebo-controlled, cross-over study after individual dose-response assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2802%2970023-9

7 January 2021

Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2802%2970023-9

7 January 2021

Conservative drug treatment in patients with moderately severe chronic occlusive peripheral arterial disease. Scandinavian Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2802%2970023-9

7 January 2021

Does pentoxifylline prolong the walking distance in exercised claudicants? A placebo-controlled double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2802%2970023-9

7 January 2021

Treatment of intermittent claudication with physical training, smoking cessation, pentoxifylline, or nafronyl: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2802%2970023-9

7 January 2021

Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2802%2970023-9

7 January 2021

Effect of Cilostazol, a Cyclic AMP Phosphodiesterase Inhibitor, on the Proliferation of Rat Aortic Smooth Muscle Cells in Culture

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2802%2970023-9

7 January 2021

A new pharmacological treatment for intermittent claudication: results of a randomized, multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2802%2970023-9

7 January 2021

Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective, double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2802%2970023-9

7 January 2021

Blood viscosity during long-term treatment with ticlopidine in patients with intermittent claudication. A double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2802%2970023-9

7 January 2021

Multicenter double-blind study of ticlopidine in the treatment of intermittent claudication and the prevention of its complications

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2802%2970023-9

7 January 2021

Randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of AS-013, a prostaglandin E1 prodrug, in patients with intermittent claudication

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2802%2970023-9

7 January 2021

Efficacy of a new prostaglandin E1 regimen in outpatients with severe intermittent claudication: results of a multicenter placebo-controlled double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2802%2970023-9

7 January 2021

Oral Beraprost sodium, a prostaglandin I(2) analogue, for intermittent claudication: a double-blind, randomized, multicenter controlled trial. Beraprost et Claudication Intermittente (BERCI) Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2802%2970023-9

7 January 2021

Naftidrofuryl in chronic arterial disease. Results of a six month controlled multicenter study using Naftidrofuryl tablets 200 mg

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2802%2970023-9

7 January 2021

Increases in walking distance in patients with peripheral vascular disease treated with L-carnitine: a double-blind, cross-over study

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2802%2970023-9

7 January 2021

Propionyl-l-carnitine in intermittent claudication: Double-blind, placebo-controlled, dose titration, multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2802%2970023-9

7 January 2021

Effect of propionyl-L-carnitine on quality of life in intermittent claudication

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2802%2970023-9

7 January 2021

EDTA chelation therapy in chronic degenerative disease

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2802%2970023-9

7 January 2021

EDTA treatment of intermittent claudication--a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2802%2970023-9

7 January 2021

Chelation therapy for peripheral arterial occlusive disease: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2802%2970023-9

7 January 2021

EDTA chelation treatment for peripheral vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2802%2970023-9

7 January 2021

Restoring vascular nitric oxide formation by l-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2802%2970023-9

7 January 2021

Ginkgo biloba extract for the treatment of intermittent claudication: a meta-analysis of randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2802%2970023-9

7 January 2021

Buflomedil in arterial occlusive disease: results of a controlled multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2802%2970023-9

7 January 2021

Randomized placebo-controlled, double-blind trial of ketanserin in claudicants. Changes in claudication distance and ankle systolic pressure. PACK Claudication Substudy

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2802%2970023-9

7 January 2021

10.1016/S0895-7967(02)70023-9

Identifiers

DOI

1 reference

5 August 2017

1 reference